Infectivity of SARS-CoV-2: there Is Something More than D614G?

J Neuroimmune Pharmacol. 2020 Dec;15(4):574-577. doi: 10.1007/s11481-020-09954-3. Epub 2020 Sep 15.

Saathvik R Kannan^{1

2}, Austin N Spratt^{1

3}, Thomas P Quinn⁴, Xiao Heng⁴, Christian L Lorson^{1

5}, Anders Sönnerborg^{6

7}, Siddappa N Byrareddy⁸, Kamal Singh^{9

10

11

12

13}

¹ Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.
² Hickman High School, Columbia, MO, 65203, USA.
³ Department of Mathematics, University of Missouri, Columbia, MO, 65211, USA.
⁴ Department of Biochemistry, University of Missouri, Columbia, MO, 65211, USA.
⁵ Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, 65211, USA.
⁶ Department of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, 65211, USA. anders.sonnerborg@ki.se.
⁷ Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Huddinge, 14186, Stockholm, Sweden. anders.sonnerborg@ki.se.
⁸ Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, 68198, USA. sid.byrareddy@unmc.edu.
⁹ Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA. singhka@missouri.edu.
¹⁰ Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, 65211, USA. singhka@missouri.edu.
¹¹ Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Huddinge, 14186, Stockholm, Sweden. singhka@missouri.edu.
¹² Shift Pharmaceuticals, Overland Park, KS, 66211, USA. singhka@missouri.edu.
¹³ Sanctum Therapeutics Corporation, Sunnyvale, CA, 94087, USA. singhka@missouri.edu.

No abstract available

Publication types